HLA-B27-Associated Acute Anterior Uveitis (HLA-B27 AAU) is a sudden inflammation of the front part of the eye—the iris (colored part) and ciliary body (just behind the iris). It is called “anterior” because it affects the front chamber of the eye, and “acute” because it comes on quickly and lasts for a short time. About half of all people who get acute anterior uveitis carry a genetic marker called HLA-B27, which makes them more likely to develop this eye inflammation EyeWikiPubMed.
HLA-B27-associated acute anterior uveitis (AAU) is a sudden inflammation of the front part of the eye, affecting the iris and ciliary body. This condition often causes pain, redness, blurred vision, and light sensitivity. It is strongly linked to the HLA-B27 gene, part of the major histocompatibility complex that helps our immune system recognize foreign substances. People who carry HLA-B27 have up to a 50–60% chance of developing AAU, and attacks tend to come on quickly, usually in one eye, then resolve over days to weeks with treatment PubMedEyeWiki.
HLA-B27 AAU most often affects men aged 20–40 and is frequently associated with systemic inflammatory diseases like ankylosing spondylitis or inflammatory bowel disease. Recurrences are common—sometimes alternating between eyes—and can lead to complications such as cataracts, glaucoma, or permanent vision loss if not managed promptly PMCNature.
In very simple terms:
-
HLA-B27 is a protein on certain cells that helps the body’s immune system recognize self from foreign substances.
-
When someone has the HLA-B27 protein, their immune system sometimes reacts too strongly in the eye, causing the iris and ciliary body to become red, sore, and watery.
-
This reaction can happen on its own or alongside other diseases (for example, arthritis).
Types of HLA-B27 Acute Anterior Uveitis
Ophthalmologists classify HLA-B27 AAU by how often it occurs and how long it lasts:
-
Acute (First Episode)
-
Comes on suddenly, usually over hours to a day.
-
Lasts less than three months and then goes away with treatment.
-
-
Recurrent
-
Returns after at least three months of no inflammation.
-
May affect the same eye again or switch to the other eye.
-
-
Chronic
-
Persists for more than three months.
-
Requires ongoing treatment to keep inflammation under control.
-
-
Fibrinous
-
A severe form where thick, whitish protein (fibrin) collects in the front chamber.
-
Can cause the iris to stick to the lens or create a cloudy layer over the pupil.
-
-
Hypopyon-forming
-
The most severe acute type, where white blood cells settle at the bottom of the front chamber, forming a visible white line (hypopyon).
-
Requires urgent treatment to prevent damage.
-
-
Granulomatous vs. Non-granulomatous
-
Non-granulomatous: Fine dust-like deposits on the inner cornea (common in HLA-B27 AAU).
-
Granulomatous: Larger, greasy-looking deposits (less common in HLA-B27 AAU).
-
These types help doctors predict how serious the attack may be and decide on the best treatment plan Uveitis.org | OIUF.
Causes (Triggers and Associated Conditions)
Below are 20 known “causes” or triggers that make someone with HLA-B27 more likely to develop acute anterior uveitis. In many cases, HLA-B27 sets the stage, and other factors spark the inflammation:
-
Genetic Predisposition (HLA-B27 Allele)
Carrying the HLA-B27 gene itself increases the risk of eye inflammation, because this version of the immune-system protein misfires more easily. -
Ankylosing Spondylitis
A form of spine arthritis in which HLA-B27 AAU occurs in up to 40% of patients. -
Reactive Arthritis (Reiter’s Syndrome)
Joint pain and eye inflammation following certain infections (for example, after a gut or urinary infection). -
Psoriatic Arthritis
An arthritis linked to the skin disease psoriasis; HLA-B27 AAU can flare up alongside skin and joint symptoms. -
Inflammatory Bowel Disease (IBD)
Conditions like Crohn’s disease or ulcerative colitis that inflame the gut can also trigger eye inflammation. -
Undifferentiated Spondyloarthritis
Early or mild forms of spine/joint inflammation that do not fit the full picture of other spondyloarthropathies. -
Enteropathic Arthritis
Joint problems arising directly from gut inflammation, often accompanied by HLA-B27 AAU. -
Salmonella Infection
Food-poisoning bacteria can precipitate reactive arthritis and eye inflammation. -
Shigella Infection
A different gut bacteria causing diarrhea that can lead to a reactive arthritis picture. -
Yersinia Infection
Another intestinal infection that may spark both joint and eye inflammation. -
Chlamydia trachomatis Infection
A urinary or genital infection that commonly precedes reactive arthritis and HLA-B27 AAU. -
Campylobacter Infection
Often from undercooked poultry, can trigger reactive arthritis and eye symptoms. -
Trauma or Eye Surgery
Injury or recent cataract surgery can break the eye’s normal immune balance, revealing HLA-B27-linked inflammation. -
Viral Illnesses
Sometimes viruses (e.g., herpes simplex) can set off anterior uveitis in those predisposed by HLA-B27. -
Systemic Viral Infections
Influenza or other systemic viral syndromes can occasionally coincide with an eye flare. -
Medications
Rarely, drugs like bisphosphonates (used for bone diseases) can bring on uveitis in susceptible people. -
Stress
Physical or emotional stress may tip the immune system toward an inflammatory attack in someone with HLA-B27. -
Hormonal Changes
Pregnancy or hormonal therapy can alter immune balance and sometimes trigger eye inflammation. -
Environmental Factors
Cold weather or high pollen counts can stress the immune system, occasionally leading to a flare. -
Unknown (“Idiopathic”) Trigger
Even without a clear infection or disease flare, many people with HLA-B27 simply develop uveitis for no obvious reason.
Each of these factors either directly inflames the eye or activates the immune system in a way that secondarily involves the iris and ciliary body.
Symptoms
When HLA-B27 AAU strikes, the front of the eye becomes inflamed. Here are the most common warning signs, written in very simple English:
-
Eye Redness
The white part of the eye turns pink or red because tiny blood vessels swell. -
Eye Pain
A dull ache or sharp pain, especially when you move your eye or look around. -
Light Sensitivity (Photophobia)
Bright lights hurt your eyes, making you squint or close them. -
Blurred Vision
Things look fuzzy or out of focus because inflammation clouds the front of your eye. -
Tearing (Excessive Tears)
Your eye may water more, like when you cry, but without feeling sad. -
Floaters
Small specks or strings drift across your vision; you might notice them in bright areas. -
Headache
Sometimes the pain spreads around your forehead or behind your eyes. -
Colored Halos
You see rainbow circles around lights, caused by fluid in the eye. -
Eye Ache
A general soreness or pressure sensation inside the eye. -
Ciliary Flush
A red ring around the iris, where the iris meets the white of the eye. -
Small Pupil (Miosis)
The dark center of your eye may become smaller than normal as the iris spasms. -
Keratic Precipitates
Fine, white deposits stick to the inner cornea; doctors see these with a slit lamp. -
Decreased Vision
If inflammation is severe, you may see less clearly or lose some vision. -
Fibrin Accumulation
Thick, whitish protein can float in the front chamber in severe cases, causing vision to dim. -
Hypopyon
In very bad flares, white blood cells settle at the bottom of the eye’s front chamber, forming a visible line.
Most people with HLA-B27 AAU experience a combination of these symptoms. The speed and severity can vary from person to person PMC.
Diagnostic Tests
A careful eye exam and a few lab and imaging tests confirm HLA-B27 AAU. Below are 20 tests, grouped by type:
A. Physical Exam
-
Visual Acuity Test
Measures how well you see at various distances using an eye chart. -
Slit-Lamp Examination
A special microscope with a bright light lets the doctor see the front structures (iris, cornea, lens) in detail. -
Intraocular Pressure Measurement (Tonometry)
Checks fluid pressure inside the eye to rule out glaucoma, which can accompany uveitis. -
Pupillary Reaction Test
Observes how the pupil responds to light and dark; a slow or irregular response suggests inflammation. -
External Eye Inspection
Doctors look for redness patterns (ciliary flush), drooping eyelid, or swelling around the eye.
B. Manual/Office Tests
-
Gonioscopy
Uses a special lens to view the drainage angle of the eye, ensuring fluid can exit properly. -
Fluorescein Staining
A bright green dye highlights corneal scratches or ulcers under blue light. -
Applanation Tonometry
Another way to measure eye pressure by gently flattening the cornea.
C. Laboratory and Pathological Tests
-
HLA-B27 Typing
A blood test to detect the HLA-B27 gene protein on white blood cells. -
Complete Blood Count (CBC)
Checks overall white blood cell levels—high counts can signal active inflammation. -
Erythrocyte Sedimentation Rate (ESR)
Measures how quickly red blood cells settle in a tube; faster rates mean more inflammation in the body. -
C-Reactive Protein (CRP)
A protein that rises in the blood when there’s inflammation anywhere in the body. -
Syphilis Serology (RPR/VDRL)
Tests for syphilis bacteria, since infection can mimic uveitis. -
Tuberculosis Screening (PPD or IGRA)
Checks for latent TB infection, which can cause eye inflammation. -
HIV Test
HIV-positive status can alter uveitis presentation and guide treatment.
D. Electrodiagnostic Tests
-
Electroretinography (ERG)
Records electrical responses of the retina to light flashes; helps rule out retinal disease. -
Visual Evoked Potential (VEP)
Measures brain responses to visual stimuli; useful if optic nerve involvement is suspected.
E. Imaging Tests
-
Optical Coherence Tomography (OCT)
A non-contact scan that shows cross-sectional images of the retina and optic nerve. -
Ultrasound B-Scan
Uses sound waves to view the back of the eye when inflammation or opacities block direct vision. -
Fluorescein Angiography
A dye test that highlights blood flow in the retina and choroid, detecting leaks or blockages.
Each test helps rule out other causes and pin down HLA-B27 AAU as the correct diagnosis Medscape.
Non-Pharmacological Treatments
These supportive and lifestyle measures help ease eye inflammation, improve comfort, and address underlying factors.
-
Ocular Rest
Putting away screens and reading material gives the eye a chance to heal. By avoiding bright lights and glare, pain and photophobia lessen. -
Cold Compresses
Gently applying a cool, damp cloth over closed eyelids reduces swelling and soothes discomfort by constricting blood vessels in the eye area. -
Protective Eyewear
Wearing wrap-around sunglasses outdoors shields the inflamed eye from UV light and wind, which can trigger pain and tearing. -
Dark Room Therapy
Staying in a dimly lit room for short periods eases light sensitivity and helps break the cycle of pain and squinting. -
Warm Compresses for Headaches
If uveitis is accompanied by tension headaches, a warm pack on the temples can relieve muscle tightness without affecting the eye directly. -
Hydration
Drinking plenty of water keeps tissues well-lubricated and supports the body’s natural healing processes. -
Cold Steam Inhalation
Inhaling cool steam (e.g., from a bowl of warm water) can reduce overall facial inflammation, indirectly easing eye discomfort. -
Stress Management
Techniques such as deep breathing, guided imagery, or mindfulness meditation help lower systemic inflammation by reducing stress hormones. -
Yoga and Tai Chi
Gentle movement improves circulation and flexibility, which may help control underlying arthritis that often accompanies HLA-B27 AAU WebMDHealthline. -
Aquatic Exercise
Water-based workouts reduce joint stress and boost mobility, benefiting those with linked ankylosing spondylitis PMC. -
Pilates and Stretching
Core strengthening and gentle stretches maintain good posture and spinal flexibility, reducing flare-ups of associated spinal inflammation Cleveland Clinic. -
Occupational Therapy
A therapist can suggest modifications (e.g., ergonomic lighting, work breaks) that minimize eye strain during daily activities. -
Acupuncture
Some patients find relief in traditional Chinese needle therapy, which may modulate inflammatory pathways, though research is still emerging. -
Massage Therapy
Light massage around the neck and shoulders can ease muscle tension and improve blood flow to the head, which may indirectly lessen ocular pain. -
Heat Therapy
Applying a warm eye mask for 5–10 minutes can relax eyelid muscles and improve tear film stability, easing irritation. -
Cold Therapy
Short cold-pack applications (wrapped in cloth) combat acute swelling in the first 24–48 hours of an attack. -
Sleep Hygiene
Ensuring 7–8 hours of quality sleep bolsters immune regulation and helps the body repair inflamed tissues. -
Anti-Inflammatory Diet
Eating plenty of fruits, vegetables, and whole grains supplies antioxidants and compounds that naturally reduce inflammation Healthline. -
Smoking Cessation
Quitting smoking cuts down on systemic inflammatory triggers, lowering the risk and severity of uveitis recurrences Wikipedia. -
Education and Self-Monitoring
Learning to recognize early symptoms (redness, pain, light sensitivity) empowers timely self-care and rapid medical attention EyeWiki.
Drug Treatments
Key medications to control inflammation, prevent damage, and address systemic disease.
-
Prednisolone Acetate 1% (Topical Steroid)
-
Class: Corticosteroid eye drop
-
Dosage: 1 drop every 1–2 hours when awake, tapering over 4–6 weeks
-
Purpose: Reduce anterior chamber inflammation
-
Mechanism: Inhibits inflammatory mediators (cytokines, prostaglandins)
-
Side Effects: Increased eye pressure, cataract formation WebEye.
-
-
Dexamethasone Intravitreal Implant
-
Class: Long-acting corticosteroid
-
Dosage: Single implant injected into vitreous, may repeat every 6 months
-
Purpose: Continuous intraocular inflammation control
-
Mechanism: Sustained release of steroid to suppress cytokine production
-
Side Effects: Glaucoma, cataract progression Wikipedia.
-
-
Cyclopentolate 1% (Cycloplegic)
-
Class: Anticholinergic eye drop
-
Dosage: 1 drop twice daily for 5–7 days
-
Purpose: Relieve pain from iris spasm and prevent posterior synechiae
-
Mechanism: Paralyzes ciliary muscle, dilates pupil
-
Side Effects: Blurred vision, light sensitivity WebEye.
-
-
Atropine 1% (Cycloplegic)
-
Class: Anticholinergic eye drop
-
Dosage: 1 drop once daily for severe cases
-
Purpose: Longer-lasting cycloplegia for comfort and synechiae prevention
-
Mechanism: Blocks muscarinic receptors in iris/ciliary body
-
Side Effects: Dry mouth, tachycardia (systemic absorption) Wikipedia.
-
-
Methotrexate
-
Class: Disease-modifying antirheumatic drug (DMARD)
-
Dosage: 7.5–25 mg once weekly (oral or subcutaneous)
-
Purpose: Control recurrent AAU and underlying spondyloarthritis
-
Mechanism: Folic acid antagonist reduces T-cell proliferation
-
Side Effects: Liver toxicity, oral ulcers, bone marrow suppression Wikipedia.
-
-
Azathioprine
-
Class: Antimetabolite immunosuppressant
-
Dosage: 1–2.5 mg/kg/day orally
-
Purpose: Steroid-sparing for recurrent uveitis
-
Mechanism: Inhibits purine synthesis, limiting lymphocyte activation
-
Side Effects: Pancreatitis, leukopenia, liver enzyme elevation Wikipedia.
-
-
Sulfasalazine
-
Class: Sulfa drug with DMARD properties
-
Dosage: 500 mg twice daily, increase to 1 g twice daily as tolerated
-
Purpose: Reduce flare frequency in spondyloarthritis-associated AAU
-
Mechanism: Anti-inflammatory via inhibition of prostaglandins
-
Side Effects: Rash, gastrointestinal upset, headache ScienceDirect.
-
-
Indomethacin
-
Class: Nonsteroidal anti-inflammatory drug (NSAID)
-
Dosage: 25 mg three times daily
-
Purpose: Mild control of inflammation, pain relief
-
Mechanism: COX-1/2 inhibition to block prostaglandin synthesis
-
Side Effects: Gastric ulceration, kidney impairment IOVS.
-
-
Adalimumab
-
Infliximab
-
Class: Anti-TNF-α monoclonal antibody
-
Dosage: 5 mg/kg IV at weeks 0, 2, 6, then every 8 weeks
-
Purpose: Rapid remission in severe or refractory AAU
-
Mechanism: Binds TNF-α, preventing receptor signaling
-
Side Effects: Infusion reactions, reactivation of latent infections PMC.
-
Dietary Molecular & Herbal Supplements
Natural compounds that may support eye health and reduce inflammation.
-
Omega-3 Fatty Acids (1,000 mg/day)
-
Function: Anti-inflammatory; improves cell membrane health
-
Mechanism: Converts to resolvins that dampen cytokine release
-
-
Curcumin (500 mg twice daily)
-
Function: Broad anti-inflammatory action
-
Mechanism: Inhibits NF-κB pathway, reducing interleukin-6 production
-
-
Green Tea Extract (EGCG) (300 mg/day)
-
Function: Antioxidant; supports immune balance
-
Mechanism: Scavenges free radicals, modulates T-cell activity
-
-
Resveratrol (150 mg/day)
-
Function: Vascular health; anti-inflammatory
-
Mechanism: Activates SIRT1, reducing oxidative stress
-
-
Quercetin (500 mg/day)
-
Function: Mast cell stabilization; antihistamine effect
-
Mechanism: Inhibits histamine release, limits leukotriene synthesis
-
-
Vitamin D3 (2,000 IU/day)
-
Function: Immune regulation
-
Mechanism: Enhances regulatory T cells and lowers Th17 activity Wikipedia.
-
-
Vitamin C (500 mg twice daily)
-
Function: Antioxidant; collagen synthesis support
-
Mechanism: Neutralizes free radicals, supports tissue repair
-
-
Beta-Carotene (15,000 IU/day)
-
Function: Precursor to Vitamin A; antioxidant
-
Mechanism: Scavenges singlet oxygen, supports epithelial health
-
-
Lutein & Zeaxanthin (10 mg/2 mg daily)
-
Function: Macular protection; filters blue light
-
Mechanism: Accumulates in retina, protects photoreceptors from oxidative damage
-
-
Bilberry Extract (160 mg twice daily)
-
Function: Capillary strength; antioxidant
-
Mechanism: Inhibits a-glucosidase, supports microvascular integrity
-
-
Ginkgo Biloba (120 mg/day)
-
Function: Microcirculation enhancement
-
Mechanism: Modulates nitric oxide pathways, improves blood flow
-
-
Alpha-Lipoic Acid (300 mg/day)
-
Function: Regenerates other antioxidants
-
Mechanism: Recycles vitamins C and E, reduces oxidative stress
-
-
Astaxanthin (8 mg/day)
-
Function: Potent antioxidant; anti-inflammatory
-
Mechanism: Inhibits COX-2 and iNOS, reducing prostaglandin synthesis
-
-
Probiotics (multi-strain, 10⁹ CFU/day)
-
Function: Gut-immune axis support
-
Mechanism: Balances gut flora, lowers systemic inflammation
-
-
Boswellia Serrata (300 mg three times daily)
-
Function: Anti-arthritic; anti-inflammatory
-
Mechanism: Inhibits 5-lipoxygenase, reducing leukotriene production
-
Regenerative & Stem Cell-Related Therapies
Advanced options under investigation or specialty centers.
-
Mesenchymal Stem Cell Therapy
-
Dosage: Single IV infusion of 1 × 10⁶ cells/kg
-
Function: Immune modulation, tissue repair
-
Mechanism: Secretes anti-inflammatory cytokines (IL-10, TGF-β)
-
-
Autologous Hematopoietic Stem Cell Transplant
-
Dosage: Conditioning chemotherapy followed by reinfusion of CD34⁺ cells
-
Function: Reset immune system in severe, refractory cases
-
Mechanism: Eliminates autoreactive lymphocytes, reconstitutes with tolerant cells
-
-
Secukinumab
-
Dosage: 150 mg subcutaneously at weeks 0, 1, 2, 3, 4 then monthly
-
Function: IL-17A blockade for refractory uveitis
-
Mechanism: Neutralizes IL-17A, reducing Th17-mediated inflammation PMC.
-
-
Abatacept
-
Dosage: 10 mg/kg IV at weeks 0, 2, 4 then monthly
-
Function: T-cell costimulation blockade
-
Mechanism: CTLA-4-Ig fusion protein prevents CD28-mediated activation
-
-
Tocilizumab
-
Dosage: 8 mg/kg IV every 4 weeks
-
Function: IL-6 receptor inhibition
-
Mechanism: Blocks IL-6 signaling, reducing acute-phase reactants
-
-
Ustekinumab
-
Dosage: 90 mg subcutaneously at weeks 0, 4 then every 12 weeks
-
Function: IL-12/23 blockade
-
Mechanism: Prevents Th1 and Th17 differentiation
-
Surgical Procedures
Reserved for complications or treatment-resistant cases.
-
Pars Plana Vitrectomy
-
Procedure: Removal of vitreous gel
-
Why: Clears inflammatory debris, improves drug delivery, treats complications like macular edema.
-
-
Cataract Extraction
-
Procedure: Phacoemulsification with lens implant
-
Why: Removes steroid- or inflammation-induced cataract to restore vision.
-
-
Trabeculectomy
-
Procedure: Creates a drainage channel for aqueous humor
-
Why: Controls uveitic glaucoma by lowering intraocular pressure.
-
-
Posterior Synechiolysis
-
Procedure: Breaks iris adhesions to lens
-
Why: Prevents pupillary block and secondary glaucoma.
-
-
Iridectomy/Iridotomy
-
Procedure: Creates small hole in iris
-
Why: Prevents angle closure in cases with iris bombé or pupillary block.
-
Prevention Strategies
-
Treat underlying spondyloarthritis promptly with DMARDs ScienceDirect.
-
Use prophylactic low-dose topical steroids between flare-ups under doctor supervision.
-
Maintain good hydration and sleep to support immune balance.
-
Wear protective eyewear in windy or dusty environments.
-
Avoid known triggers (e.g., infections, UV overexposure).
-
Follow a low-starch, anti-inflammatory diet for ankylosing spondylitis Wikipedia.
-
Quit smoking to reduce systemic inflammation Wikipedia.
-
Keep blood sugar under control in diabetic patients.
-
Schedule regular ophthalmology follow-ups (every 3–6 months).
-
Monitor and manage stress with relaxation techniques.
When to See a Doctor
-
Severe or worsening eye pain or redness.
-
New floaters or sudden vision changes.
-
Intense light sensitivity (photophobia).
-
Headache with nausea or vomiting.
-
Any symptoms in both eyes or prolonged beyond 48 hours PMC.
What to Eat & What to Avoid
Eat More:
-
Colorful fruits and vegetables (berries, leafy greens) for antioxidants.
-
Omega-3-rich fish (salmon, mackerel).
-
Whole grains and legumes for fiber.
-
Nuts and seeds (flaxseed, walnuts) for healthy fats.
-
Turmeric and ginger for natural anti-inflammation.
Avoid:
-
High-starch foods (white bread, pasta) linked to ankylosing spondylitis flares Wikipedia.
-
Processed sugars and trans fats that fuel inflammation.
-
Excessive alcohol, which can impair immune response.
-
High-salt snacks that may worsen blood pressure.
-
Artificial additives and preservatives.
15 Frequently Asked Questions
-
What causes HLA-B27 AAU?
A mix of genetic factors (HLA-B27) and immune triggers leads to inflammation in the eye ﹘ often linked with spondyloarthritis. -
How is it diagnosed?
An eye exam with slit lamp, blood test for HLA-B27, and imaging if needed. -
Can it affect both eyes?
Yes, but usually one eye at a time; it can alternate between eyes over time. -
Is vision loss permanent?
If treated early, vision usually recovers fully; delays can lead to lasting damage. -
How long does a flare last?
With proper treatment, most flares resolve in 2–6 weeks. -
Will it come back?
Recurrences are common; about 70% of patients have multiple episodes. -
Can children get it?
It’s rare in children but can occur, especially if they carry HLA-B27. -
Is it contagious?
No; it is an immune-mediated condition, not an infection. -
Can diet really help?
An anti-inflammatory diet may reduce systemic inflammation and lower flare frequency. -
Do I always need steroids?
Topical steroids are first-line for acute flares, but long-term use is minimized to avoid side effects. -
What if I can’t tolerate steroids?
Steroid-sparing drugs (DMARDs or biologics) can control flare-ups. -
Are supplements safe?
Most are safe at recommended doses, but always discuss with your doctor before starting. -
Is surgery common?
Surgery is only for complications like cataracts or glaucoma that don’t respond to medicine. -
How often should I see my doctor?
At least every 3–6 months, or sooner if you notice new symptoms. -
Can exercise worsen my eyes?
Gentle exercise helps by controlling underlying arthritis; avoid strenuous activity during a flare.
Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.
The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members
Last Updated: August 06, 2025.